Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors

The determination of Human Chorionic Gonadotropin (hCG) and Alpha Fetoprotein (AFP) levels on serum and amniotic fluid plays a fundamental role in the diagnosis and follow-up of specific physiological or pathological conditions (e.g., pregnancy, threat of abortion or germ cell tumors). Recently, the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Annamaria D'Alessandro, Domenico Ciavardelli, Anna Pastore, Germana Giannone, Giada Del Baldo, Andrea Carai, Angela Mastronuzzi, Andrea Onetti Muda, Ottavia Porzio
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
AFP
hCG
Acceso en línea:https://doaj.org/article/eaa7a5fb9003413fb1b4ac9128126353
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eaa7a5fb9003413fb1b4ac9128126353
record_format dspace
spelling oai:doaj.org-article:eaa7a5fb9003413fb1b4ac91281263532021-11-25T17:20:27ZCerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors10.3390/diagnostics111119802075-4418https://doaj.org/article/eaa7a5fb9003413fb1b4ac91281263532021-10-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/1980https://doaj.org/toc/2075-4418The determination of Human Chorionic Gonadotropin (hCG) and Alpha Fetoprotein (AFP) levels on serum and amniotic fluid plays a fundamental role in the diagnosis and follow-up of specific physiological or pathological conditions (e.g., pregnancy, threat of abortion or germ cell tumors). Recently, the quantification of hCG and AFP in other biological fluids has gained great attention to support the diagnosis, prognosis and follow-up of neoplastic diseases deriving from trophoblastic cells, such as germinomas. Most of the commercial kits for hCG and AFP assays are developed to be used on biological fluids such as serum/plasma and/or urine by manufacturing companies. The aim of this work was to evaluate the suitability of the analytical method certified for the use on serum, and/or amniotic fluid for the quantification of hCG and AFP in cerebrospinal fluid, carrying out an internal validation protocol. The data reported here show that the automated immunochemical method is fit for quantification of hCG and AFP in cerebrospinal fluid (CSF), allowing selective and specific diagnosis of secreting germ cell tumors. This is confirmed by the positive correlation between elevated levels of hCG or AFP and the diagnosis of brain tumors.Annamaria D'AlessandroDomenico CiavardelliAnna PastoreGermana GiannoneGiada Del BaldoAndrea CaraiAngela MastronuzziAndrea Onetti MudaOttavia PorzioMDPI AGarticleAFPhCGcerebrospinal fluidgerm cell tumorscentral nervous system tumorsMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 1980, p 1980 (2021)
institution DOAJ
collection DOAJ
language EN
topic AFP
hCG
cerebrospinal fluid
germ cell tumors
central nervous system tumors
Medicine (General)
R5-920
spellingShingle AFP
hCG
cerebrospinal fluid
germ cell tumors
central nervous system tumors
Medicine (General)
R5-920
Annamaria D'Alessandro
Domenico Ciavardelli
Anna Pastore
Germana Giannone
Giada Del Baldo
Andrea Carai
Angela Mastronuzzi
Andrea Onetti Muda
Ottavia Porzio
Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
description The determination of Human Chorionic Gonadotropin (hCG) and Alpha Fetoprotein (AFP) levels on serum and amniotic fluid plays a fundamental role in the diagnosis and follow-up of specific physiological or pathological conditions (e.g., pregnancy, threat of abortion or germ cell tumors). Recently, the quantification of hCG and AFP in other biological fluids has gained great attention to support the diagnosis, prognosis and follow-up of neoplastic diseases deriving from trophoblastic cells, such as germinomas. Most of the commercial kits for hCG and AFP assays are developed to be used on biological fluids such as serum/plasma and/or urine by manufacturing companies. The aim of this work was to evaluate the suitability of the analytical method certified for the use on serum, and/or amniotic fluid for the quantification of hCG and AFP in cerebrospinal fluid, carrying out an internal validation protocol. The data reported here show that the automated immunochemical method is fit for quantification of hCG and AFP in cerebrospinal fluid (CSF), allowing selective and specific diagnosis of secreting germ cell tumors. This is confirmed by the positive correlation between elevated levels of hCG or AFP and the diagnosis of brain tumors.
format article
author Annamaria D'Alessandro
Domenico Ciavardelli
Anna Pastore
Germana Giannone
Giada Del Baldo
Andrea Carai
Angela Mastronuzzi
Andrea Onetti Muda
Ottavia Porzio
author_facet Annamaria D'Alessandro
Domenico Ciavardelli
Anna Pastore
Germana Giannone
Giada Del Baldo
Andrea Carai
Angela Mastronuzzi
Andrea Onetti Muda
Ottavia Porzio
author_sort Annamaria D'Alessandro
title Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
title_short Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
title_full Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
title_fullStr Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
title_full_unstemmed Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
title_sort cerebrospinal fluid levels of afp and hcg: validation of the analytical method and application in the diagnosis of central nervous system germ cell tumors
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/eaa7a5fb9003413fb1b4ac9128126353
work_keys_str_mv AT annamariadalessandro cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT domenicociavardelli cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT annapastore cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT germanagiannone cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT giadadelbaldo cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT andreacarai cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT angelamastronuzzi cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT andreaonettimuda cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
AT ottaviaporzio cerebrospinalfluidlevelsofafpandhcgvalidationoftheanalyticalmethodandapplicationinthediagnosisofcentralnervoussystemgermcelltumors
_version_ 1718412503972577280